239 related articles for article (PubMed ID: 4924220)
21. Immune status in untreated patients with lymphoreticular malignancy--a multifactorial study.
Hancock BW; Bruce L; Sugden P; Ward AM; Richmond J
Clin Oncol; 1977 Mar; 3(1):57-63. PubMed ID: 324686
[No Abstract] [Full Text] [Related]
22. Serum levels of second component of complement in cancer patients.
Southam CM; Siegel AH
J Immunol; 1966 Sep; 97(3):331-7. PubMed ID: 5332649
[No Abstract] [Full Text] [Related]
23. [Monoclonal immunoglobulin in patients with malignant lymphoma].
Chu DT
Zhonghua Zhong Liu Za Zhi; 1986 Jan; 8(1):16-9. PubMed ID: 3732019
[TBL] [Abstract][Full Text] [Related]
24. [Studies of cell content and surface and secretory immunoglobulins in myeloma, macroglobulinemia, malignant lymphoma and related leukemic diseases].
Miyoshi K; Kosaka M; Tamora R; Numata Y; Takamato M
Nihon Rinsho; 1976 May; 34(5):945-53. PubMed ID: 824476
[No Abstract] [Full Text] [Related]
25. Immunoglobulin types and features of multiple myeloma in northern Nigeria.
Onyemelukwe GC; Kulkarni AG
East Afr Med J; 1988 Jan; 65(1):33-8. PubMed ID: 3416793
[No Abstract] [Full Text] [Related]
26. [Serum immunoglobulin in Hodgkin's disease].
Del Giacco GS; Tognella S; Manconi PE; Mantovani G; Spano G; Grifoni V
Boll Soc Ital Biol Sper; 1970 Apr; 46(8):413-7. PubMed ID: 4993885
[No Abstract] [Full Text] [Related]
27. [Serum immunoglobulins in non-Hodgkin's lymphoma].
Gola A; Nowicka J; Starzyk H; Niewolna M; Frydecka I
Pol Tyg Lek; 1986 Mar; 41(13):417-9. PubMed ID: 3755239
[No Abstract] [Full Text] [Related]
28. [Hypogammaglobulinemia in patients with the syndrome of absorption disorders].
Kuvaeva IB; Vinogradova MA; Temkina TIa; Kamaeva NG; Makeeva AA
Klin Med (Mosk); 1974; 52(8):124-31. PubMed ID: 4214178
[No Abstract] [Full Text] [Related]
29. Evaluation of immunologic reactivity of lymphocytes from patients with chronic lymphocytic leukemia in various clinical conditions.
Traczyk Z; Cieśluk S; Litwin J; Arczyńska E
Arch Immunol Ther Exp (Warsz); 1975; 23(5):589-96. PubMed ID: 766725
[No Abstract] [Full Text] [Related]
30. Malignant lymphomas of B-cell type.
Stein H; Lennert K; Parwaresch MR
Lancet; 1972 Oct; 2(7782):855-7. PubMed ID: 4116558
[No Abstract] [Full Text] [Related]
31. [Immunoglobulin composition of the blood in hemolymphoblastosis].
Medina F; Tognella S
Folia Allergol (Roma); 1967; 14(6):447-52. PubMed ID: 4171226
[No Abstract] [Full Text] [Related]
32. [Polyclonal immunoglobulins in serum in obligatory and facultative monoclonal gammopathies].
Hrncírová L; Máchová L
Vnitr Lek; 1982 Feb; 28(2):116-21. PubMed ID: 6801853
[No Abstract] [Full Text] [Related]
33. Immunoglobulin levels in Hodgkin's disease.
Madaliński K; Brzosko WJ; Zulawski M
Haematologia (Budap); 1970; 4(3):333-41. PubMed ID: 5001993
[No Abstract] [Full Text] [Related]
34. Serum immunoglobulin levels in patients with Hodgkin's disease: relation to disease activity and clinical stage.
Douer D; Pick AI; Kessler E; Vana D; Kenan Z
Clin Oncol; 1978 Sep; 4(3):209-13. PubMed ID: 750123
[No Abstract] [Full Text] [Related]
35. Naturally occurring and therapy-induced antibodies to human granulocyte colony-stimulating factor (G-CSF) in human serum.
Laricchia-Robbio L; Moscato S; Genua A; Liberati AM; Revoltella RP
J Cell Physiol; 1997 Nov; 173(2):219-26. PubMed ID: 9365526
[TBL] [Abstract][Full Text] [Related]
36. [Means of approaching a nosologic classification of lymph node sarcomas].
Chelloul N
Bull Cancer; 1974; 61(1):35-6. PubMed ID: 4617608
[No Abstract] [Full Text] [Related]
37. [IgM monoclonal gammapathies: a spectrum of hematologic-clinical options (analysis of 24 cases)].
Sánchez Fayos J; Outeiriño J; Ortíz Masllorens F; Pérez Piño T; de Villalobos E; Calleja JL; Paniagua G
Rev Clin Esp; 1975 Sep; 138(6):507-13. PubMed ID: 1105700
[No Abstract] [Full Text] [Related]
38. [IgG, IgA and IgM levels in Hodgkin's disease].
Dziewulska-Bakiniec A; Piskorzyńska M
Wiad Lek; 1981 Apr; 34(8):635-8. PubMed ID: 7303678
[No Abstract] [Full Text] [Related]
39. The management of plasma cell neoplasms.
Lee BJ; Pinsky C; Miller DG
Med Clin North Am; 1971 May; 55(3):703-19. PubMed ID: 4995917
[No Abstract] [Full Text] [Related]
40. [Cytotoxic antibodies in hematosarcomas].
Moulinier J; Hoerni B; Merle MC; Mothey C
Bord Med; 1972 Jun; 5(11):1291-4. PubMed ID: 4560012
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
